High prevalence of asymptomatic nosocomial candiduria due to Candida glabrata among hospitalized patients with heart failure: a matter of some concern?

سال انتشار: 1399
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 51

فایل این مقاله در 8 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_CUMM-6-4_001

تاریخ نمایه سازی: 9 آذر 1402

چکیده مقاله:

Background and Purpose: Heart failure is a leading cause of hospitalization, and asymptomatic candiduria is common in hospitalized patients with low morbidity. However, in most patients, it is resolved spontaneously on the removal of the catheter. Despite the publication of guidelines, there are still controversies over the diagnosis and management of candiduria. However, in hospitalized patients with heart failure, the decision to treat candiduria is especially important since the nosocomial infections are associated with an increase in morbidity, mortality, length of hospital stay, and healthcare costs. Some species of Candida, such as Candida glabrata, are increasingly resistant to the first-line and second-line antifungal medications. The present study aimed to investigate the incidence of asymptomatic Candida urinary tract infection due to C. glabrata and antifungal susceptibility of Candida isolates in hospitalized patients with heart failure. Materials and Methods: In total, ۳۰۵ hospitalized patients with heart failure were studied to identify asymptomatic nosocomial candiduria during ۲۰۱۶-۱۷ in one private hospital in the north of Iran. The Sabouraud’s dextrose agar culture plates with a colony count of >۱۰۴ colony-forming unit/ml of urine sample were considered as Candida urinary tract infection. Candida species were identified based on the morphology of CHROMagar Candida (manufactured by CHROMagar, France) and PCR-RFLP method with MspI restriction enzyme. Antifungal susceptibility testing of the isolates was performed using five mediations, including itraconazole, voriconazole, fluconazole, amphotericin B, and caspofungin by broth microdilution method according to CLSI M۲۷-S۴. Results: In this study, the rate of asymptomatic Candida urinary tract infection was ۱۸.۸%, which was more common in people above ۵۱ years old and females (۷۰%). In addition to the urinary and intravascular catheter, the occurrence of candiduria in hospitalized patients had significant relationships with a history of surgical intervention, diastolic heart failure, and use of systemic antibiotics (P>۰.۰۵). Among Candida spp., non-albicans Candida species was the most common infectious agent (۵۹.۷%). Moreover, C. glabrata (n=۲۷, ۴۰.۳%) (alone or with other species) and Candida albicans (n=۲۷, ۴۰.۳%) were the most common agents isolated in Candida urinary tract infection. Based on the results of the in vitro susceptibility test, the C. glabrata isolates were ۱۵%, ۵۹%, ۷۰%, ۷۴%, and ۸۵% susceptible to caspofungin, amphotericin B, itraconazole, voriconazole, and fluconazole, respectively. Conclusion: According to the findings, there was a high prevalence of asymptomatic Candida urinary tract infection in hospitalized patients with heart failure. Besides, it was suggested that there was a shift towards non-albicans Candida, especially C. glabrata, in these patients. Therefore, asymptomatic candiduria in hospitalized patients with heart failure should be considered significant. Furthermore, the identification of Candida species along with antifungal susceptibility is essential and helps the clinicians to select the appropriate antifungal agent for better management of such cases.

نویسندگان

Seyed Reza Aghili

Invasive Fungi Research Center, Communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran

Mahdi Abastabar

Invasive Fungi Research Center, Communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran

Ameneh Soleimani

Department of Medical Mycology, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran

Iman Haghani

Invasive Fungi Research Center, Communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran

Soheil Azizi

Department of Laboratory Medicine, Faculty of Allied Medical Sciences, Mazandaran University of medical science, Sari, Iran

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • ۱ Fonarow GC. Epidemiology and risk stratification in acute heart ...
  • Vasiliadis I, Kolovou G, Kolovou V, Giannakopoulou V, Boutsikou M, ...
  • Dai S, Walsh P, Wielgosz A, Gurevich Y, Bancej C, ...
  • Alon D, Stein GY, Korenfeld R, Fuchs S. Predictors and ...
  • Montgomery K. Urinary tract infections and the heart. Acupuncture Today. ...
  • Foxman B. Epidemiology of urinary tract infections: incidence, morbidity, and ...
  • Tannenbaum C, Johnell K. Managing therapeutic competition in patients with ...
  • Bronsema DA, Adams JR, Pallares R, Wenzel RP. Secular trends ...
  • Richards MJ, Edwards JR, Culver DH, Gaynes RP. Nosocomial infections ...
  • Eriksen HM, Iversen BG, Aavitsland P. Prevalence of nosocomial infections ...
  • Ghiasian SA, Aghamirian MR, Eshghi GR. Nosocomial candiduria in critically ...
  • Kauffman CA. Candiduria. Clin Infect Dis. ۲۰۰۵; ۴۱(Suppl ۶):S۳۷۱-۶ ...
  • Pappas PG, Kauffman CA, Andes D, Benjamin DK Jr, Calandra ...
  • Ozhak-Baysan B, Ogunc D, Colak D, Ongut G, Donmez L, ...
  • Kauffman CA, Fisher JF, Sobel JD, Newman CA. Candida urinary ...
  • Kauffman CA, Vasquez JA, Sobel JD, Gallis HA, McKinsey DS, ...
  • Falahati M, Farahyar S, Akhlaghi L, Mahmoudi S, Sabzian K, ...
  • Colombo AL, Garnica M, Aranha Camargo LF, Da Cunha CA, ...
  • Xiao M, Fan X, Chen SC, Wang H, Sun ZY, ...
  • Wiederhold NP. Antifungal resistance: current trends and future strategies to ...
  • Mohammadi R, Mirhendi H, Rezaei-Matehkolaei A, Ghahri M, Shidfar MR, ...
  • Abastabar M, Hosseinpoor S, Hedayati MT, Shokohi T, Valadan R, ...
  • Clinical and Laboratory Standards Institute.Reference method for broth dilution antifungal ...
  • Clinical Laboratory and Standards Institute (CLSI). Reference method for broth ...
  • Santos ER, Dal Forno CF, Hernandez MG, Kubiça TF, Venturini ...
  • Zarei Mahmoudabadi A, Keradmand AR, Enayatollahi N. Frequency of candiduria ...
  • PakshirK, Moghadami M, Emami M, Kord Bacheh P. Prevalence and ...
  • Goyal RK, Sami H, Mishra V, Bareja R, Behara RN. ...
  • Colonder R, Nuri Y, Chazan B, Raz R. Community-acquired and ...
  • GulerS, Ural O, Findik D, Arslan U. Risk factors for ...
  • García-Agudo L, Rodríguez-Iglesias M, Carranza-González R. Nosocomial Candiduria in the ...
  • Kane LE, Muzevich KM. Micafungin in the treatment of candiduria: ...
  • Talebitaher M, Naimi T, Shayanfar N, Nojomi M, Barati M. ...
  • Harris AD, Castro J, Sheppard DC, Carmeli Y, Samore MH. ...
  • Achkar JM, Fries BC. Candida infections of the genitourinary tract. ...
  • Ullah A, Lopes MI, Brul S, Smits GJ. Intracellular pH ...
  • Rodrigues CF, Rodrigues ME, Henriques M. Candida sp. infections in ...
  • Kaur R, Dhakad MS, Goyal R, Kumar R. Emergence of ...
  • Silva S, Negri M, Henriques M, Oliveira R, Williams DW, ...
  • Sousa IA, Braoios A, Santos TG, Lima JA, Costa RM. ...
  • Behzadi P, Behzadi E, Ranjbar R. Urinary tract infections and ...
  • Sanguinetti M, Posteraro B, Lass-Flörl C. Antifungal drug resistance among ...
  • Rossoni RD, Barbosa JO, Vilela SF, dos Santos JD, de ...
  • Yang YL, Chu WL, Lin CC, Zhou ZL, Chen PN, ...
  • Gharaghani M, Taghipour S, Halvaeezadeh M, Mahmoudabadi AZ. Candiduria; a ...
  • Zarei-Mahmoudabadi A, Zarrin M, Ghanatir F, Vazirianzadeh B.Candiduria in hospitalized ...
  • Yapar N. Epidemiology and risk factors for invasive candidiasis. Ther ...
  • The global market for medical devices. Market Research Group, LLC. ...
  • Jang AY, O’Brien C, Chung WJ, Oh PC, Yu J, ...
  • Darouiche RO. Device-associated infections: a macro-problem that starts with micro-adherence. ...
  • Azad N, Kathiravelu A, Minoosepeher S, Hebert P, Fergusson D. ...
  • Ho KK, Pinsky JL, Kannel WB, Levy D. The epidemiology ...
  • Dalen JE, Alpert JS, Goldberg RJ, Weinstein RS. The epidemic ...
  • Weinstein RA, Lundstrom T, Sobel J. Nosocomial candiduria: a review. ...
  • Bandeira AC, Filho JM, de Almeida Ramos K. Reversible cardiomyopathy ...
  • Bukhary ZA. Candiduria: a review of clinical significance and management. ...
  • Mishra M, Agrawal S, Raut S, Kurhade AM, Powar RM. ...
  • Esmailzadeh A, Zarrinfar H, Fata A, Sen T. High prevalence ...
  • Fazeli A, Kordbacheh P, Nazari A, Daie Ghazvini R, Mirhendi ...
  • Yismaw G, Asrat D, Woldeamanuel Y, Unakal C. Prevalence of ...
  • Shokohi T, Bandalizadeh Z, Hedayati MT, Mayahi S. In vitro ...
  • Aslani N, Shokohi T, Ataollahi MR, Ansari S, Gholampour Y, ...
  • Sanguinetti M, Posteraro B, Fiori B, Ranno S, Torelli R, ...
  • Amirrajab N, Badali H, Didehdar M, Afsarian MH, Mohammadi R, ...
  • Bayraktar S, Duran N, Duran GG, Eryilmaz N, Aslan H, ...
  • Daef E, Moharram A, Eldin SS, Elsherbiny N, Mohammed M. ...
  • نمایش کامل مراجع